SCHEMBL50063

SCHEMBL50063

CCC(C)CCCCC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.53
FFAR1 O14842 2/20 0.53
AKR1B1 P15121 1/20 0.52
ALDH1A1 P00352 3/20 0.52
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 4/20 0.50
PTPN1 P18031 3/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50
ESR1 P03372 1/20 0.50
ALOX15 P16050 1/20 0.50
PDE4A P27815 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9499158 1.00 FFAR4 (0.53) FFAR4FFAR1AKR1B1ALDH1A1GPR84
SCHEMBL6373776 1.00 FFAR4 (0.53) FFAR4FFAR1AKR1B1ALDH1A1GPR84
SCHEMBL2483372 0.98 FFAR4 (0.57) FFAR4FFAR1AKR1B1ALDH1A1GPR84
SCHEMBL22612557 0.98 FFAR4 (0.57) FFAR4FFAR1AKR1B1ALDH1A1GPR84
SCHEMBL4285232 0.98 FFAR4 (0.57) FFAR4FFAR1AKR1B1ALDH1A1GPR84
SCHEMBL347119 0.98 FFAR4 (0.57) FFAR4FFAR1AKR1B1ALDH1A1GPR84
SCHEMBL22612525 0.98 FFAR4 (0.57) FFAR4FFAR1AKR1B1ALDH1A1GPR84
SCHEMBL22612553 0.98 FFAR4 (0.57) FFAR4FFAR1AKR1B1ALDH1A1GPR84
Hydrochloric Acid SCHEMBL10695203 0.98 FFAR4 (0.52) FFAR4FFAR1AKR1B1ALDH1A1GPR84
SCHEMBL1333784 0.98 FFAR4 (0.57) FFAR4FFAR1AKR1B1ALDH1A1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1865 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12448418-B2 Activatable therapeutic peptides and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-10-21 US claimed
US-20250320174-A1 SPIN ON METAL-ORGANIC FORMULATIONS MERCK PATENTS GMBH (DE) 2025-10-16 US claimed
CN-119985741-A Detection method of non-amino acid impurities in polymyxin B sulfate for injection 江苏利泰尔药业有限公司 2025-05-13 CN claimed
CN-119020084-B Water-resistant refrigerator oil and preparation method thereof 浙江康力博能源科技有限公司 2025-04-25 CN claimed
CN-119372002-A Refrigerator oil and working fluid composition 珠海格力电器股份有限公司 2025-01-28 CN claimed
CN-119020084-A Water-resistant refrigerator oil and preparation method thereof 浙江康力博能源科技有限公司 2024-11-26 CN claimed
EP-3218013-B1 MOLECULAR PROBES FOR DETECTING GRAM-NEGATIVE BACTERIA IN VITRO AND IN VIVO UNIV COURT UNIV OF EDINBURGH (GB) 2024-04-17 EP claimed
CN-117380269-B Oil-soluble organic molybdenum catalyst and preparation method and application thereof 北京高新利华科技股份有限公司 2024-04-05 CN claimed
EP-4334252-A2 SPIN ON METAL-ORGANIC FORMULATIONS Merck Patent GmbH (DE) 2024-03-13 EP claimed
CN-117380269-A Oil-soluble organic molybdenum catalyst and preparation method and application thereof 北京高新利华科技股份有限公司 2024-01-12 CN claimed
US-20150158805-A1 Method for Producing Isononanoic Acid Esters, Starting from 2-Ethyl Hexanol OXEA GMBH (DE) 2015-06-11 US claimed
US-8425784-B2 Ozonolysis reactions in liquid CO2 and CO2-expanded solvents UNIVERSITY OF KANSAS (US) 2013-04-23 US claimed
EP-2120586-A2 ADJUVANTS AND METHODS OF USING THEM Archer-Daniels-Midland Company (US) 2009-11-25 EP claimed
WO-2008100896-A2 ADJUVANTS AND METHODS OF USING THEM ARCHER-DANIELS-MIDLAND COMPANY (US) 2008-08-21 WO claimed
US-20080194410-A1 acidificers propionic acid, methyl acetic acid, acetic acid, lactic acid, fumaric acid, citric acid, phosphoric acid mixed with lecithin emulsifier; nonphenolic nonionic surfactant such as ethoxylated monolycerides, fatty acid ethoxylates, polyoxyethylene alkyl ethers, polyoxyethylene alkyl esters; water ARCHER DANIELS MIDLAND COMPANY 2008-08-14 US claimed
EP-0506463-B1 New compounds, named the \"leustroducsins\" their preparation and their therapeutic uses SANKYO CO (JP) 1996-02-28 EP claimed
US-5443972-A Fermentation of Streptomyces SANKYO COMPANY, LIMITED (JP) 1995-08-22 US claimed
US-5334587-A For adverse reactions from cancer chemotherapy, infections, cerebral dysfunction or fungal infection SANKYO COMPANY, LIMITED (JP) 1994-08-02 US claimed
EP-0506463-A2 New compounds, named the \"leustroducsins\" their preparation and their therapeutic uses Sankyo Company Limited (JP) 1992-09-30 EP claimed
US-4091092-A ANTIBIOTIC MIXTURE PRODUCED BY BACILLUS CIRCULANS E. R. SQUIBB & SONS, INC. (US) 1978-05-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320174-A1 SPIN ON METAL-ORGANIC FORMULATIONS SLC39A11, SLC39A3, SLC39A7 FFAR4 3848/4885FFAR1 3654/4885AKR1B1 3723/4885
US-12448418-B2 Activatable therapeutic peptides and uses thereof TPX2, HM13, XPNPEP1 FFAR4 2171/4885FFAR1 4087/4885AKR1B1 4435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.